168 related articles for article (PubMed ID: 9819794)
1. Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy.
ten Bokkel Huinink WW; de Swart CA; van Toorn DW; Morack G; Breed WP; Hillen HF; van der Hoeven JJ; Reed NS; Fairlamb DJ; Chan SY; Godfrey KA; Kristensen GB; van Tinteren H; Ehmer B
Med Oncol; 1998 Sep; 15(3):174-82. PubMed ID: 9819794
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR
Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study.
Oberhoff C; Neri B; Amadori D; Petry KU; Gamucci T; Rebmann U; Nowrousian MR; Voigtmann R; Monfardini S; Armand JP; Herrmann R; Netter-Pinon J; Tubiana-Mathieu N; Zwierzina H
Ann Oncol; 1998 Mar; 9(3):255-60. PubMed ID: 9602258
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumours.
Csáki C; Ferencz T; Schuler D; Borsi JD
Eur J Cancer; 1998 Feb; 34(3):364-7. PubMed ID: 9640223
[TBL] [Abstract][Full Text] [Related]
5. Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer.
Cheer SM; Wagstaff AJ
Drugs; 2004; 64(3):323-46. PubMed ID: 14871172
[TBL] [Abstract][Full Text] [Related]
6. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma.
Osterborg A; Boogaerts MA; Cimino R; Essers U; Holowiecki J; Juliusson G; Jäger G; Najman A; Peest D
Blood; 1996 Apr; 87(7):2675-82. PubMed ID: 8639883
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin in patients with ovarian carcinoma and anaemia secondary to cisplatin and carboplatin chemotherapy: preliminary results.
James RD; Wilkinson PM; Belli F; Welch R; Cowan R
Acta Haematol; 1992; 87 Suppl 1():12-5. PubMed ID: 1574960
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients.
Mantovani G; Ghiani M; Curreli L; Maccio A; Massa D; Succu G; Lai P; Massa E; Mudu MC; Astara G
Oncol Rep; 1999; 6(2):421-6. PubMed ID: 10023014
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin in the treatment of cancer-related anaemia.
Kasper C; Terhaar A; Fosså A; Welt A; Seeber S; Nowrousian MR
Eur J Haematol; 1997 Apr; 58(4):251-6. PubMed ID: 9186536
[TBL] [Abstract][Full Text] [Related]
11. Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia.
Thews O; Koenig R; Kelleher DK; Kutzner J; Vaupel P
Br J Cancer; 1998 Sep; 78(6):752-6. PubMed ID: 9743294
[TBL] [Abstract][Full Text] [Related]
12. Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.
Hensley ML; Lebeau D; Leon LF; Venkatraman E; Waltzman R; Sabbatini P; Almadrones L; Chi D; Spriggs D
Gynecol Oncol; 2001 Jun; 81(3):485-9. PubMed ID: 11371143
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
Ludwig H; Sundal E; Pecherstorfer M; Leitgeb C; Bauernhofer T; Beinhauer A; Samonigg H; Kappeler AW; Fritz E
Cancer; 1995 Dec; 76(11):2319-29. PubMed ID: 8635038
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin in autologous blood donors: a dose-finding study.
Biesma DH; Kraaijenhagen RJ; Dalmulder J; Marx JJ; Van De Wiel A
Br J Haematol; 1994 Jan; 86(1):30-5. PubMed ID: 8011544
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer.
Welch RS; James RD; Wilkinson PM; Belli F; Cowan RA
Cancer J Sci Am; 1995; 1(4):261-6. PubMed ID: 9166486
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.
Quirt I; Micucci S; Moran LA; Pater J; Browman G
Cancer Prev Control; 1997 Aug; 1(3):241-8. PubMed ID: 9765749
[TBL] [Abstract][Full Text] [Related]
17. Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation.
Baron F; Sautois B; Baudoux E; Matus G; Fillet G; Beguin Y
Exp Hematol; 2002 Jun; 30(6):546-54. PubMed ID: 12063021
[TBL] [Abstract][Full Text] [Related]
18. Management of chemotherapy-induced anemia.
Eguchi K
Curr Opin Oncol; 1995 Jul; 7(4):316-9. PubMed ID: 7578378
[TBL] [Abstract][Full Text] [Related]
19. Early treatment of premature infants with recombinant human erythropoietin.
Messer J; Haddad J; Donato L; Astruc D; Matis J
Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery.
Kaufner L; von Heymann C; Henkelmann A; Pace NL; Weibel S; Kranke P; Meerpohl JJ; Gill R
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012451. PubMed ID: 32790892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
